期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 87, 期 3, 页码 362-366出版社
WILEY
DOI: 10.1038/clpt.2009.285
关键词
-
In recent years, drug development has become dramatically globalized, and global clinical trials (GCTs) are being conducted in both International Conference on Harmonisation (ICH) and non-ICH regions. 1 To ensure the success of global drug development, ethnicity-related factors must be taken into consideration. In this article, the experiences and initiatives of the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan are described, and the contours of an effective global drug development strategy are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据